Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2010-08-27Clinical Trial Update: Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating induction chemotherapy before surgery in operable non-small cell lung cancer has been withdrawn.
-
EMA withdrawal · 2010-03-26EMA Application withdrawn: Docetaxel Mylan (docetaxel) — Mylan S.A.S.
Withdrawal of the EMA application for Docetaxel Mylan (docetaxel) by Mylan S.A.S., affecting multiple solid tumor indications including non-…
-
CLINICAL_TRIALS withdrawal · 2010-02-04Clinical Trial Update: Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel [Phase 1]
A Phase 1 study evaluating AZD0530 (saracatinib) in combination with carboplatin and paclitaxel has been withdrawn, with conditions includin…
-
CLINICAL_TRIALS withdrawal · 2009-09-18Clinical Trial Update: Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3 [Phase 3]
A Phase 3 trial evaluating neoadjuvant chemotherapy for non-small cell lung cancer in stages IB, IIA, IIB, and IIIA/T3 has been terminated.